Company / EPS (Basic)
enGene Holdings Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$2.29
FY2025
5-year range
$1.46 / $151.22
FY2022-FY2025
Trend
+56.8%
vs FY2024
Sector context
#27 of 207
Health Care
What the data says
enGene Holdings Inc.'s eps (basic) of $2.29 is higher than 87% of companies in the Health Care sector (FY2025). Declined from $151.22 to $2.29 over the past 2 years.
Based on SEC 10-K filings.
2.29 in FY2025 with a 3-year CAGR of -62.7%. Top quartile in the Health Care sector.
Declined from $151.22 to $2.29 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -62.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 207This company $2.29 Sector average -$0.42
▼
+646.8% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 56.8% year-over-year.
- Ranks #27 out of 207 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.29 | +56.8% |
| FY2024 | $1.46 | -99.0% |
| FY2023 | $151.22 | +241.4% |
| FY2022 | $44.30 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026